Results 11 to 20 of about 135 (50)

Training providers to improve access to emergency contraception in abortion ban states in the U.S. [PDF]

Reprod Health
Mundaden R, Alvarez A, Zia Y, Comfort A, Brandi K, Goodman S, Harper CC.   +6 more
europepmc   +1 more source

Evaluation of marketing authorization and clinical implementation of ulipristal acetate for uterine fibroids. [PDF]

Hum Reprod, 2022
Middelkoop MA, de Lange ME, Clark TJ, Mol BWJ, Bet PM, Huirne JAF, Hehenkamp WJK.   +6 more
europepmc   +1 more source

Medical treatment of fibroids: FIGO best practice guidance. [PDF]

Int J Gynaecol Obstet
Diaz I, Lumsden MA, Zeppernick M.
europepmc   +1 more source

Phase III long-term study to evaluate the efficacy and safety of ulipristal acetate in Japanese patients with uterine fibroids. [PDF]

J Obstet Gynaecol Res, 2021
Osuga Y, Nakano Y, Yamauchi Y, Murakawa H.   +3 more
europepmc   +1 more source

Petroclival meningioma regression after combined oestrogen and nomegestrol acetate interruption. [PDF]

BMJ Case Rep
Lebeau J, Deprez L, Pintiaux A, Reuter G.   +3 more
europepmc   +1 more source

Liver Injury with Ulipristal Acetate: Exploring the Underlying Pharmacological Basis. [PDF]

Drug Saf, 2020
Gatti M, Poluzzi E, De Ponti F, Raschi E.   +3 more
europepmc   +1 more source

A plain language summary describing changes in pain associated with uterine fibroids among women receiving relugolix combination therapy. [PDF]

Pain Manag
Stewart EA, Lukes AS, Venturella R, Ferreira JA, Li Y, Hunsche E, Wagman RB, Al-Hendy A.   +7 more
europepmc   +1 more source

"My BMI is too high for Plan B." A changing population of women seeking ulipristal acetate emergency contraception online. [PDF]

Women Health, 2020
Cleland K, Wagner B, Smith NK, Trussell J.   +3 more
europepmc   +1 more source

Changes in symptom burden and quality of life among women with uterine fibroids receiving relugolix combination therapy: a plain language summary. [PDF]

J Comp Eff Res
Stewart EA, Lukes AS, Venturella R, Li Y, Hunsche E, Wagman RB, Al-Hendy A.   +6 more
europepmc   +1 more source

Local Transdermal Delivery of Telapristone Acetate Through Breast Skin, Compared With Oral Treatment: A Randomized Double-Blind, Placebo-Controlled Phase II Trial. [PDF]

Clin Pharmacol Ther, 2021
Lee O, Pilewskie M, Karlan S, Tull MB, Benante K, Xu Y, Blanco L, Helenowski I, Kocherginsky M, Yadav S, Hosseini O, Hansen N, Bethke K, Muzzio M, Troester MA, Dimond E, Perloff M, Heckman-Stoddard B, Khan SA.   +18 more
europepmc   +1 more source